#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4357677	B	Inhibition of Serratia marcescens chitinase b catalytic domain overexpressed in Escherichia coli BL21(DE3) cells at 1 uM using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis	Serratia marcescens	23	ALA4354842	cell-based format	Scientific Literature
2.	ALA4357678	B	Inhibition of Ostrinia furnacalis chitinase h catalytic domain overexpressed in Pichia pastoris at 1 uM using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis	Ostrinia furnacalis	23	ALA4354842	assay format	Scientific Literature
3.	ALA4357679	B	Inhibition of human acidic mammalian chitinase catalytic domain overexpressed in Pichia pastoris at 10 uM using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis	Homo sapiens	23	ALA4354842	assay format	Scientific Literature
4.	ALA4357680	B	Inhibition of human CHIT1 catalytic domain overexpressed in Pichia pastoris at 10 uM using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis	Homo sapiens	23	ALA4354842	assay format	Scientific Literature
5.	ALA4357681	B	Selectivity ratio of Ki for inhibition of mouse acidic mammalian chitinase catalytic domain overexpressed in Pichia pastoris to Ki for inhibition of mouse CHIT1 catalytic domain overexpressed in Pichia pastoris	Mus musculus	1	ALA4354842	assay format	Scientific Literature
6.	ALA4357682	B	Selectivity ratio of Ki for inhibition of human acidic mammalian chitinase catalytic domain overexpressed in Pichia pastoris to Ki for inhibition of human CHIT1 catalytic domain overexpressed in Pichia pastoris	Homo sapiens	1	ALA4354842	assay format	Scientific Literature
7.	ALA4357683	B	Inhibition of Serratia marcescens chitinase b catalytic domain overexpressed in Escherichia coli BL21(DE3) cells using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis	Serratia marcescens	2	ALA4354842	cell-based format	Scientific Literature
8.	ALA4357684	B	Inhibition of Ostrinia furnacalis chitinase h catalytic domain overexpressed in Pichia pastoris using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis	Ostrinia furnacalis	2	ALA4354842	assay format	Scientific Literature
9.	ALA4357685	B	Inhibition of mouse acidic mammalian chitinase catalytic domain overexpressed in Pichia pastoris using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis	Mus musculus	2	ALA4354842	assay format	Scientific Literature
10.	ALA4357686	B	Inhibition of mouse CHIT1 catalytic domain overexpressed in Pichia pastoris using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis	Mus musculus	2	ALA4354842	assay format	Scientific Literature
11.	ALA4357687	B	Inhibition of human acidic mammalian chitinase catalytic domain overexpressed in Pichia pastoris using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis	Homo sapiens	2	ALA4354842	assay format	Scientific Literature
12.	ALA4357688	B	Inhibition of human CHIT1 catalytic domain overexpressed in Pichia pastoris using 4MU-(GlcNAc)2 as substrate after 30 mins by fluorescence based microplate reader analysis	Homo sapiens	2	ALA4354842	assay format	Scientific Literature
13.	ALA4357691	F	Invivo inhibition of human chitinase in C57BL/6 mouse assesed as reduction in bleomycin-induced chitinase level in BALF at 2 ug/mouse, ip administered for 11 days and measured on day 12 by necropsy analysis	Mus musculus	1	ALA4354842	organism-based format	Scientific Literature
14.	ALA4357692	B	Inhibition of chitinase in mouse BALF at 40 ug using 4-MU-(GlcNAc)2 substrate as substrate after 15 mins relative to control	Mus musculus	1	ALA4354842	single protein format	Scientific Literature
15.	ALA4357693	B	Inhibition of chitinase in mouse BALF at 1 ug using 4-MU-(GlcNAc)2 substrate as substrate after 15 mins relative to control	Mus musculus	1	ALA4354842	single protein format	Scientific Literature
16.	ALA4357694	F	Antifibrotic activity in bleomycin-induced C57BL/6 mouse model of pulmonary fibrosis assessed as effect on Chit1 expression at 2 ug/mouse, ip administered for 11 days and measured on day 12 post treatment by RT-qPCR analysis	Mus musculus	1	ALA4354842	organism-based format	Scientific Literature
17.	ALA4357695	F	Antifibrotic activity in bleomycin-induced C57BL/6 mouse model of pulmonary fibrosis assessed as effect on Areg expression at 2 ug/mouse, ip administered for 11 days and measured on day 12 post treatment by RT-qPCR analysis	Mus musculus	1	ALA4354842	organism-based format	Scientific Literature
18.	ALA4357696	F	Antifibrotic activity in bleomycin-induced C57BL/6 mouse model of pulmonary fibrosis assessed as effect on TGFbeta expression at 2 ug/mouse, ip administered for 11 days and measured on day 12 post treatment by RT-qPCR analysis	Mus musculus	1	ALA4354842	organism-based format	Scientific Literature
19.	ALA4357697	F	Antifibrotic activity in bleomycin-induced C57BL/6 mouse model of pulmonary fibrosis assessed as effect on IL33 expression at 2 ug/mouse, ip administered for 11 days and measured on day 12 post treatment by RT-qPCR analysis	Mus musculus	1	ALA4354842	organism-based format	Scientific Literature
20.	ALA4357698	F	Antifibrotic activity in bleomycin-induced C57BL/6 mouse model of pulmonary fibrosis assessed as effect on IL5 expression at 2 ug/mouse, ip administered for 11 days and measured on day 12 post treatment by RT-qPCR analysis	Mus musculus	1	ALA4354842	organism-based format	Scientific Literature